SINGH BIOTECHNOLOGY

Singh Biotechnology is a pre-clinical stage company that is developing a pipeline of highly selective novel single domain antibodies (sdAbs) around its proprietary technology for targeting intracellular proteins to treat a wide range of diseases including cancers, autoimmune and ophthalmic diseases... Singh Biotechnology (SBT) is a biotechnology organization that is in the business of discovering and developing unique and propriety therapeutic agents for the treatment of a variety of diseases (cancers, autoimmune, and ophthalmologic diseases) by leveraging our novel technology platform... At Singh Biotechnology we use our novel proprietary disruptive technology single domain antibody (sdAb) platform to create miniature antibodies that comprise solely of the variable region and therefore the sdAb is devoid of light chains. Using our proprietary technology we have engineered our sdAbs to be specific & bi-specific, with the ability to cross the cell membrane as well as the blood brain..

Also known as: Singh Biotechnology, LLC

Primary location: Lutz United States